| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |